| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |